H. H. Chao Comprehensive Digestive Center, University of California Irvine Medical Center, Orange, USA.
Dig Endosc. 2021 Jan;33(1):54-65. doi: 10.1111/den.13661. Epub 2020 Apr 17.
Intervention for liver disease has predominantly been performed through the percutaneous approach. However, as endoscopic ultrasound (EUS) applications have expanded, there have emerged various EUS-guided interventions for liver disease, a space we call "Endo-Hepatology". EUS-guided liver biopsy can be considered the "forerunner" of Endo-Hepatology and has become a clinical option for patients requiring histologic diagnosis and staging of their liver disease. EUS also enables direct access to the portal vein. Subsequently, many procedures are being explored, such as angiography, measurement of the portosystemic pressure gradient, portal vein sampling to detect cancer cell or DNA, and EUS-guided transhepatic intrahepatic portosystemic shunt creation. Since the transducer is close to the liver, especially the left and caudate lobes, EUS can be used as a rescue when the percutaneous approach is not favorable and EUS-guided treatments of liver tumor, cyst and abscess have been reported. This review summarizes the available studies of EUS-guided intervention in the liver.
经皮途径一直是肝脏疾病干预的主要手段。然而,随着内镜超声(EUS)应用的扩展,已经出现了各种 EUS 引导的肝脏疾病干预方法,我们称之为“内镜肝脏病学”。EUS 引导下肝活检可以被视为“内镜肝脏病学”的先驱,并且已经成为需要进行肝脏疾病组织学诊断和分期的患者的一种临床选择。EUS 还可以直接进入门静脉。随后,正在探索许多程序,例如血管造影、门脉系统压力梯度测量、门静脉取样以检测癌细胞或 DNA,以及 EUS 引导下经肝内肝内门体分流术的创建。由于换能器靠近肝脏,特别是左叶和尾叶,因此当经皮途径不利时,EUS 可以用作一种挽救手段,并且已经报道了 EUS 引导下肝脏肿瘤、囊肿和脓肿的治疗。本综述总结了 EUS 引导下肝脏干预的现有研究。